Search Results - "Lundstam, Sven"

Glycosaminoglycan Profiling in Patients’ Plasma and Urine Predicts the Occurrence of Metastatic Clear Cell Renal Cell Carcinoma by Gatto, Francesco, Volpi, Nicola, Nilsson, Helén, Nookaew, Intawat, Maruzzo, Marco, Roma, Anna, Johansson, Martin E., Stierner, Ulrika, Lundstam, Sven, Basso, Umberto, Nielsen, Jens

“…Metabolic reprogramming is a hallmark of clear cell renal cell carcinoma (ccRCC) progression. Here, we used genome-scale metabolic modeling to elucidate…”
Get full text

Renal cell carcinoma recurrences and metastases in primary non-metastatic patients: a population-based study by Dabestani, Saeed, Thorstenson, Andreas, Lindblad, Per, Harmenberg, Ulrika, Ljungberg, Börje, Lundstam, Sven

Get full text

Overall survival in Swedish patients with renal cell carcinoma treated in the period 2002 to 2012: Update of the RENCOMP study with subgroup analysis of the synchronous metastatic and elderly populations by Lindskog, Magnus, M.D., Ph.D, Wahlgren, Thomas, M.D., Ph.D, Sandin, Rickard, Ph.D, Kowalski, Jan, M.Sc, Jakobsson, Maria, Ph.D, Lundstam, Sven, M.D., Ph.D, Ljungberg, Börje, M.D, Harmenberg, Ulrika, M.D., Ph.D

“…Abstract Background This retrospective study investigated overall survival (OS) and factors influencing OS in Swedish patients with metastatic renal cell…”
Get full text

Plasma and Urine Free Glycosaminoglycans as Monitoring Biomarkers in Nonmetastatic Renal Cell Carcinoma-A Prospective Cohort Study by Gatto, Francesco, Dabestani, Saeed, Bratulic, Sinisa, Limeta, Angelo, Maccari, Francesca, Galeotti, Fabio, Volpi, Nicola, Stierner, Ulrika, Nielsen, Jens, Lundstam, Sven

“…No liquid biomarkers are approved in renal cell carcinoma (RCC), making early detection of recurrence in surgically treated nonmetastatic (M0) patients…”
Get full text

Metastatic Potential in Renal Cell Carcinomas ≤7cm: Swedish Kidney Cancer Quality Register Data by Guðmundsson, Eirikur, Hellborg, Henrik, Lundstam, Sven, Erikson, Stina, Ljungberg, Börje

“…Renal cell carcinoma (RCC) represents 2–3% of all malignancies and accounts for approximately 90% of all kidney malignancies. An increasing proportion of RCCs…”
Get full text

Histopathological upstage, recurrence, and survival in a population-based cohort of surgically treated patients with clinical T1b renal cell carcinoma by Lundstam, Sven, Karlsson Rosenblad, Andreas, Ljungberg, Borje

“…731 Background: T1 renal cell carcinoma (RCC) is considered to have a low malignant potential. Partial nephrectomy (PN) is recommended for nephron sparing…”
Get full text

Renal cell carcinoma recurrences and metastases in primary non-metastatic patients: a population-based study by Dabestani, Saeed, Thorstenson, Andreas, Lindblad, Per, Harmenberg, Ulrika, Ljungberg, Börje, Lundstam, Sven

“…Purpose To present the occurrence of metastases and local recurrences in primary non-metastatic patients with renal cell carcinoma (RCC) in a contemporary…”
Get full text

A phase I/II, open label, single arm study on safety, tolerability and anti-tumour effiacy of orellanine treatment in patients with metastatic clear-cell or papillary renal cell carcinoma by Lundstam, Sven, Haraldsson, Boerje, Nystrom, Jenny, Yachnin, Jeffrey

“…TPS486 Background: Poisoning by the mushroom ”deadly webcap”( Cortinarius sp.) causes irreversible kidney damage but there are no known effects on other…”
Get full text

Plasma and urine free glycosaminoglycans as monitoring and predictive biomarkers in metastatic renal cell carcinoma: A prospective observational study by Gatto, Francesco, Bratulic, Sinisa, Jonasch, Eric, Limeta, Angelo, Maccari, Francesca, Galeotti, Fabio, Volpi, Nicola, Lundstam, Sven, Nielsen, Jens, Stierner, Ulrika

“…Abstract only e16540 Background: No liquid biomarkers are approved in renal cell carcinoma (RCC). In metastatic RCC (mRCC), there is a need to predict and…”
Get full text

Metastatic Potential in Renal Cell Carcinomas ≤7 cm: Swedish Kidney Cancer Quality Register Data by Guðmundsson, Eirikur, Hellborg, Henrik, Lundstam, Sven, Erikson, Stina, Ljungberg, Börje

“…Abstract Background Renal cell carcinoma (RCC) represents 2–3% of all malignancies and accounts for approximately 90% of all kidney malignancies. An increasing…”
Get full text

End-stage renal disease after renal cancer surgery: risk factors and overall survival by Åkerlund, John, Ljungberg, Börje, Lundstam, Sven, Peeker, Ralph, Holmberg, Erik, Månsson, Marianne, Grenabo Bergdahl, Anna

“…Several risk factors for end-stage renal disease (ESRD), in patients undergoing surgical treatment for renal cell carcinoma (RCC), have been suggested by…”
Get more information

Renal angiomyolipoma-patient characteristics and treatment with focus on active surveillance by Swärd, Jesper, Henrikson, Olof, Lyrdal, David, Peeker, Ralph, Lundstam, Sven

“…To present a patient material of renal angiomyolipoma (AML) with focus on the risk of bleeding during active surveillance (AS). Medical records, 1999-2014,…”
Get more information

Detection of any-stage cancer using plasma and urine glycosaminoglycans by Gatto, Francesco, Bratulic, Sinisa, Cavarretta, Ilaria Teresa Rita, Alfano, Massimo, Maccari, Francesca, Galeotti, Fabio, Volpi, Nicola, Edqvist, Per-Henrik, Levin, Max, Nyman, Jan, Bergman, Bengt, Salonia, Andrea, Lundstam, Sven, Stierner, Ulrika, Kjölhede, Henrik, Nielsen, Jens

“…Abstract only 3034 Background: Non-invasive liquid biopsies promise to enable early cancer detection and improve patient outcomes. However, virtually all…”
Get full text

Reply to Letter to the Editor about “Recurrences after nephron-sparing treatments of renal cell carcinoma: a competing risk analysis” by Qiang et al by Rosenblad, Andreas Karlsson, Hashim, Bassam Mazin, Lindblad, Per, Ljungberg, Börje

Get full text

Treatment and overall survival in renal cell carcinoma: a Swedish population-based study (2000–2008) by Wahlgren, T, Harmenberg, U, Sandström, P, Lundstam, S, Kowalski, J, Jakobsson, M, Sandin, R, Ljungberg, B

“…Background: This retrospective register study assessed overall survival (OS) and influential factors on OS in Swedish renal cell carcinoma (RCC) patients…”
Get full text

Glycosaminoglycan profiling in patients’ plasma and urine predicts the occurrence of metastatic clear cell renal cell carcinoma by Gatto, Francesco, Volpi, Nicola, Nilsson, Helén, Nookaew, Intawat, Maruzzo, Marco, Roma, Anna, Johansson, Martin E., Stierner, Ulrika, Lundstam, Sven, Basso, Umberto, Nielsen, Jens

Get full text

Practice patterns for the surgical treatment of T1 renal cell carcinoma: a nationwide population-based register study by Ljungberg, Börje, Gudmundsson, Eirikur, Christensen, Stina, Lundstam, Sven

“…Treatment of renal cell carcinoma (RCC) with radical nephrectomy (RN) induces chronic kidney disease more frequently compared with nephron-sparing surgery…”
Get more information

Improved outcome with combined US/CT guidance as compared to US guidance in percutaneous radiofrequency ablation of small renal masses by Andersson, Mats, Hashimi, Farida, Lyrdal, David, Lundstam, Sven, Hellström, Mikael

“…When performing percutaneous radiofrequency ablation (RFA) of small renal masses (SRM), use of optimized periprocedural image guidance is essential to secure…”
Get more information

Predictive characteristics for disease recurrence and overall survival in non-metastatic clinical T1 renal cell carcinoma - results from the National Swedish Kidney Cancer Register by Almdalal, Tarik, Karlsson Rosenblad, Andreas, Hellström, Mikael, Kjellman, Anders, Lindblad, Per, Lundstam, Sven, Sundqvist, Pernilla, Ljungberg, Börje

“…Patients with clinical T1 renal cell carcinoma (cT1RCC) have risks for recurrence and reduced overall survival despite being in the best prognostic group. This…”
Get more information

Increased risk for renal cell carcinoma in end stage renal disease - a population-based case-control study by Åkerlund, John, Holmberg, Erik, Lindblad, Per, Stendahl, Maria, Ljungberg, Börje, Thorstenson, Andreas, Lundstam, Sven

“…End-stage renal disease (ESRD) is a known risk factor for the development of renal cell carcinoma (RCC). This case-control study was performed to assess the…”
Get more information